Literature DB >> 7905489

The multiple interactional biological processes that might lead to depression and gender differences in its appearance.

U Halbreich1, L A Lumley.   

Abstract

Several neurotransmitter systems have been implicated in the pathophysiology of depression. Gender differences have been demonstrated in some functions that involve these systems, mostly norepinephrine, serotonin, dopamine and acetylcholine. Several hormonal systems have been shown to be altered in depression and gender differences were demonstrated in their activity as well, notably in thyroid hormones and the hypothalamic-pituitary-adrenal system. Most gender differences in brain systems and their hormonal modulators might be attributed to developmental and state influences of gonadal hormones. It is suggested that gender differences in mechanisms that might underlie formation of depressive symptoms might be related mostly to interactional processes and destabilization of balance among multiple factors or circuitry in the central nervous system. Indeed, gender differences in specific neurotransmitters and hormonal systems can be demonstrated as well.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905489     DOI: 10.1016/0165-0327(93)90030-n

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  16 in total

1.  Reduced sleep spindle activity in early-onset and elevated risk for depression.

Authors:  Jorge Lopez; Robert Hoffmann; Roseanne Armitage
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-07-24       Impact factor: 8.829

2.  Transcranial magnetic stimulation induces alterations in brain monoamines.

Authors:  D Ben-Shachar; R H Belmaker; N Grisaru; E Klein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Sex Differences in the Relationship between Depressive Symptoms and Risk of Amnestic Mild Cognitive Impairment.

Authors:  Erin E Sundermann; Mindy J Katz; Richard B Lipton
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-09       Impact factor: 4.105

4.  Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women.

Authors:  Vonetta M Dotson; Alan B Zonderman; Michael A Kraut; Susan M Resnick
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-13       Impact factor: 3.485

Review 5.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.

Authors:  Niels Bergemann; Peter Parzer; Susanne Jaggy; Beatrice Auler; Christoph Mundt; Sabine Maier-Braunleder
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

7.  Estrogen prevents norepinephrine alpha-2a receptor reversal of stress-induced working memory impairment.

Authors:  Rebecca M Shansky; Genevieve Bender; A F T Arnsten
Journal:  Stress       Date:  2009-09       Impact factor: 3.493

8.  Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice.

Authors:  Cecilie Bay-Richter; Shorena Janelidze; Analise Sauro; Richard Bucala; Jack Lipton; Tomas Deierborg; Lena Brundin
Journal:  J Neuroinflammation       Date:  2015-09-04       Impact factor: 8.322

9.  Social class and gender patterning of insomnia symptoms and psychiatric distress: a 20-year prospective cohort study.

Authors:  Michael J Green; Colin A Espie; Michael Benzeval
Journal:  BMC Psychiatry       Date:  2014-05-25       Impact factor: 3.630

10.  How equal is the relationship between individual social capital and psychological distress? A gendered analysis using cross-sectional data from Ghent (Belgium).

Authors:  Veerle Vyncke; Wim Hardyns; Wim Peersman; Lieven Pauwels; Peter Groenewegen; Sara Willems
Journal:  BMC Public Health       Date:  2014-09-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.